An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial. Koren MJ, Vega RB, Agrawal N, Xu Y, et al. J Am Coll Cardiol 2025;85:1996-2007.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Koren MJ, Vega RB, Agrawal N, Xu Y, et al. An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial. J Am Coll Cardiol 2025;85:1996-2007.
PMID: 40167413